6-(3,5-dimethylpyrazol-1-yl)-N-(3-methyl-7,11-dihydro-6H-naphtho[1,2-e]benzimidazol-11-id-2-yl)-N-phenylfuro[3,2-d][1,3]oxazol-2-amine;diphenyl-[2-(2-pyrrolo[2,3-b]pyridin-1-ylpyrido[3,2-b][1,4]benzothiazin-10-yl)quinolin-8-yl]phosphanium;2-[12-(1-methylimidazol-4-yl)-14-thia-8,10-diazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(16),2,4,6,9,11(15),12-heptaen-8-yl]-6-phenylfuro[3,2-d][1,3]oxazole;phenyl-[2-(2-quinolin-8-yl-5,6-dihydropyrido[2,3-b][1]benzazepin-11-yl)furo[3,2-d][1,3]oxazol-6-yl]methanethiolate;tetrakis(rhodium)

C133H91N20O6PRh4S3-2 — CID 157134692

About 6-(3,5-dimethylpyrazol-1-yl)-N-(3-methyl-7,11-dihydro-6H-naphtho[1,2-e]benzimidazol-11-id-2-yl)-N-phenylfuro[3,2-d][1,3]oxazol-2-amine;diphenyl-[2-(2-pyrrolo[2,3-b]pyridin-1-ylpyrido[3,2-b][1,4]benzothiazin-10-yl)quinolin-8-yl]phosphanium;2-[12-(1-methylimidazol-4-yl)-14-thia-8,10-diazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(16),2,4,6,9,11(15),12-heptaen-8-yl]-6-phenylfuro[3,2-d][1,3]oxazole;phenyl-[2-(2-quinolin-8-yl-5,6-dihydropyrido[2,3-b][1]benzazepin-11-yl)furo[3,2-d][1,3]oxazol-6-yl]methanethiolate;tetrakis(rhodium)

6-(3,5-dimethylpyrazol-1-yl)-N-(3-methyl-7,11-dihydro-6H-naphtho[1,2-e]benzimidazol-11-id-2-yl)-N-phenylfuro[3,2-d][1,3]oxazol-2-amine;diphenyl-[2-(2-pyrrolo[2,3-b]pyridin-1-ylpyrido[3,2-b][1,4]benzothiazin-10-yl)quinolin-8-yl]phosphanium;2-[12-(1-methylimidazol-4-yl)-14-thia-8,10-diazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(16),2,4,6,9,11(15),12-heptaen-8-yl]-6-phenylfuro[3,2-d][1,3]oxazole;phenyl-[2-(2-quinolin-8-yl-5,6-dihydropyrido[2,3-b][1]benzazepin-11-yl)furo[3,2-d][1,3]oxazol-6-yl]methanethiolate;tetrakis(rhodium) (PubChem CID 157134692) has the molecular formula C133H91N20O6PRh4S3-2 and a molecular weight of 2604.12 g/mol. Its IUPAC name is 6-(3,5-dimethylpyrazol-1-yl)-N-(3-methyl-7,11-dihydro-6H-naphtho[1,2-e]benzimidazol-11-id-2-yl)-N-phenylfuro[3,2-d][1,3]oxazol-2-amine;diphenyl-[2-(2-pyrrolo[2,3-b]pyridin-1-ylpyrido[3,2-b][1,4]benzothiazin-10-yl)quinolin-8-yl]phosphanium;2-[12-(1-methylimidazol-4-yl)-14-thia-8,10-diazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(16),2,4,6,9,11(15),12-heptaen-8-yl]-6-phenylfuro[3,2-d][1,3]oxazole;phenyl-[2-(2-quinolin-8-yl-5,6-dihydropyrido[2,3-b][1]benzazepin-11-yl)furo[3,2-d][1,3]oxazol-6-yl]methanethiolate;tetrakis(rhodium).

Molecular Properties

• Compound Name: 6-(3,5-dimethylpyrazol-1-yl)-N-(3-methyl-7,11-dihydro-6H-naphtho[1,2-e]benzimidazol-11-id-2-yl)-N-phenylfuro[3,2-d][1,3]oxazol-2-amine;diphenyl-[2-(2-pyrrolo[2,3-b]pyridin-1-ylpyrido[3,2-b][1,4]benzothiazin-10-yl)quinolin-8-yl]phosphanium;2-[12-(1-methylimidazol-4-yl)-14-thia-8,10-diazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(16),2,4,6,9,11(15),12-heptaen-8-yl]-6-phenylfuro[3,2-d][1,3]oxazole;phenyl-[2-(2-quinolin-8-yl-5,6-dihydropyrido[2,3-b][1]benzazepin-11-yl)furo[3,2-d][1,3]oxazol-6-yl]methanethiolate;tetrakis(rhodium)
• PubChem CID: 157134692
• Molecular Formula: C133H91N20O6PRh4S3-2
• Molecular Weight: 2604.12 g/mol
• Exact Mass: 2602.26
• IUPAC Name: 6-(3,5-dimethylpyrazol-1-yl)-N-(3-methyl-7,11-dihydro-6H-naphtho[1,2-e]benzimidazol-11-id-2-yl)-N-phenylfuro[3,2-d][1,3]oxazol-2-amine;diphenyl-[2-(2-pyrrolo[2,3-b]pyridin-1-ylpyrido[3,2-b][1,4]benzothiazin-10-yl)quinolin-8-yl]phosphanium;2-[12-(1-methylimidazol-4-yl)-14-thia-8,10-diazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(16),2,4,6,9,11(15),12-heptaen-8-yl]-6-phenylfuro[3,2-d][1,3]oxazole;phenyl-[2-(2-quinolin-8-yl-5,6-dihydropyrido[2,3-b][1]benzazepin-11-yl)furo[3,2-d][1,3]oxazol-6-yl]methanethiolate;tetrakis(rhodium)
• SMILES: Cc1cc(C)n(-c2coc3oc(N(c4ccccc4)c4nc5c6c(ccc5n4C)CCc4ccc[c-]c4-6)nc23)n1.Cn1cnc(-c2csc3cc4c5ccccc5n(-c5nc6c(-c7[c-]cccc7)coc6o5)c4nc23)c1.[Rh].[Rh].[Rh].[Rh].[S-]C(c1ccccc1)c1coc2oc(N3c4ccccc4CCc4ccc(-c5cccc6cccnc56)nc43)nc12.c1ccc([PH+](c2ccccc2)c2cccc3ccc(N4c5ccccc5Sc5ccc(-n6ccc7cccnc76)nc54)nc23)cc1
• InChI: InChI=1S/C39H26N5PS.C34H24N4O2S.C32H25N6O2.C28H16N5O2S.4Rh/c1-3-13-29(14-4-1)45(30-15-5-2-6-16-30)32-18-9-11-27-20-22-36(41-37(27)32)44-31-17-7-8-19-33(31)46-34-21-23-35(42-39(34)44)43-26-24-28-12-10-25-40-38(28)43;41-31(23-9-2-1-3-10-23)26-20-39-33-30(26)37-34(40-33)38-28-14-5-4-8-21(28)15-16-24-17-18-27(36-32(24)38)25-13-6-11-22-12-7-19-35-29(22)25;1-19-17-20(2)38(35-19)26-18-39-30-29(26)34-32(40-30)37(23-10-5-4-6-11-23)31-33-28-25(36(31)3)16-15-22-14-13-21-9-7-8-12-24(21)27(22)28;1-32-12-21(29-15-32)20-14-36-23-11-18-17-9-5-6-10-22(17)33(26(18)30-24(20)23)28-31-25-19(13-34-27(25)35-28)16-7-3-2-4-8-16;;;;/h1-26H;1-14,17-20,31,41H,15-16H2;4-11,15-18H,13-14H2,1-3H3;2-7,9-15H,1H3;;;;/q;;2*-1
• InChIKey: WHNLGMJMEQUTFJ-UHFFFAOYSA-N
• XLogP: 30.76
• TPSA: 267.89 Ų
• H-Bond Acceptors: 29
• Rotatable Bonds: 16
• Heavy Atoms: 167
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	2604.12
LogP ≤ 5	30.76
H-Bond Donors ≤ 5	0
H-Bond Acceptors ≤ 10	29

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}, {'alert_name': 'phosphor', 'substructure': 'N/A'}, {'alert_name': 'thiol_1', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 6-(3,5-dimethylpyrazol-1-yl)-N-(3-methyl-7,11-dihydro-6H-naphtho[1,2-e]benzimidazol-11-id-2-yl)-N-phenylfuro[3,2-d][1,3]oxazol-2-amine;diphenyl-[2-(2-pyrrolo[2,3-b]pyridin-1-ylpyrido[3,2-b][1,4]benzothiazin-10-yl)quinolin-8-yl]phosphanium;2-[12-(1-methylimidazol-4-yl)-14-thia-8,10-diazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(16),2,4,6,9,11(15),12-heptaen-8-yl]-6-phenylfuro[3,2-d][1,3]oxazole;phenyl-[2-(2-quinolin-8-yl-5,6-dihydropyrido[2,3-b][1]benzazepin-11-yl)furo[3,2-d][1,3]oxazol-6-yl]methanethiolate;tetrakis(rhodium)?

The IUPAC name of 6-(3,5-dimethylpyrazol-1-yl)-N-(3-methyl-7,11-dihydro-6H-naphtho[1,2-e]benzimidazol-11-id-2-yl)-N-phenylfuro[3,2-d][1,3]oxazol-2-amine;diphenyl-[2-(2-pyrrolo[2,3-b]pyridin-1-ylpyrido[3,2-b][1,4]benzothiazin-10-yl)quinolin-8-yl]phosphanium;2-[12-(1-methylimidazol-4-yl)-14-thia-8,10-diazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(16),2,4,6,9,11(15),12-heptaen-8-yl]-6-phenylfuro[3,2-d][1,3]oxazole;phenyl-[2-(2-quinolin-8-yl-5,6-dihydropyrido[2,3-b][1]benzazepin-11-yl)furo[3,2-d][1,3]oxazol-6-yl]methanethiolate;tetrakis(rhodium) (CID 157134692) is 6-(3,5-dimethylpyrazol-1-yl)-N-(3-methyl-7,11-dihydro-6H-naphtho[1,2-e]benzimidazol-11-id-2-yl)-N-phenylfuro[3,2-d][1,3]oxazol-2-amine;diphenyl-[2-(2-pyrrolo[2,3-b]pyridin-1-ylpyrido[3,2-b][1,4]benzothiazin-10-yl)quinolin-8-yl]phosphanium;2-[12-(1-methylimidazol-4-yl)-14-thia-8,10-diazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(16),2,4,6,9,11(15),12-heptaen-8-yl]-6-phenylfuro[3,2-d][1,3]oxazole;phenyl-[2-(2-quinolin-8-yl-5,6-dihydropyrido[2,3-b][1]benzazepin-11-yl)furo[3,2-d][1,3]oxazol-6-yl]methanethiolate;tetrakis(rhodium).

What is the SMILES notation for 6-(3,5-dimethylpyrazol-1-yl)-N-(3-methyl-7,11-dihydro-6H-naphtho[1,2-e]benzimidazol-11-id-2-yl)-N-phenylfuro[3,2-d][1,3]oxazol-2-amine;diphenyl-[2-(2-pyrrolo[2,3-b]pyridin-1-ylpyrido[3,2-b][1,4]benzothiazin-10-yl)quinolin-8-yl]phosphanium;2-[12-(1-methylimidazol-4-yl)-14-thia-8,10-diazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(16),2,4,6,9,11(15),12-heptaen-8-yl]-6-phenylfuro[3,2-d][1,3]oxazole;phenyl-[2-(2-quinolin-8-yl-5,6-dihydropyrido[2,3-b][1]benzazepin-11-yl)furo[3,2-d][1,3]oxazol-6-yl]methanethiolate;tetrakis(rhodium)?

The canonical SMILES for 6-(3,5-dimethylpyrazol-1-yl)-N-(3-methyl-7,11-dihydro-6H-naphtho[1,2-e]benzimidazol-11-id-2-yl)-N-phenylfuro[3,2-d][1,3]oxazol-2-amine;diphenyl-[2-(2-pyrrolo[2,3-b]pyridin-1-ylpyrido[3,2-b][1,4]benzothiazin-10-yl)quinolin-8-yl]phosphanium;2-[12-(1-methylimidazol-4-yl)-14-thia-8,10-diazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(16),2,4,6,9,11(15),12-heptaen-8-yl]-6-phenylfuro[3,2-d][1,3]oxazole;phenyl-[2-(2-quinolin-8-yl-5,6-dihydropyrido[2,3-b][1]benzazepin-11-yl)furo[3,2-d][1,3]oxazol-6-yl]methanethiolate;tetrakis(rhodium) is Cc1cc(C)n(-c2coc3oc(N(c4ccccc4)c4nc5c6c(ccc5n4C)CCc4ccc[c-]c4-6)nc23)n1.Cn1cnc(-c2csc3cc4c5ccccc5n(-c5nc6c(-c7[c-]cccc7)coc6o5)c4nc23)c1.[Rh].[Rh].[Rh].[Rh].[S-]C(c1ccccc1)c1coc2oc(N3c4ccccc4CCc4ccc(-c5cccc6cccnc56)nc43)nc12.c1ccc([PH+](c2ccccc2)c2cccc3ccc(N4c5ccccc5Sc5ccc(-n6ccc7cccnc76)nc54)nc23)cc1.

What is the InChIKey of 6-(3,5-dimethylpyrazol-1-yl)-N-(3-methyl-7,11-dihydro-6H-naphtho[1,2-e]benzimidazol-11-id-2-yl)-N-phenylfuro[3,2-d][1,3]oxazol-2-amine;diphenyl-[2-(2-pyrrolo[2,3-b]pyridin-1-ylpyrido[3,2-b][1,4]benzothiazin-10-yl)quinolin-8-yl]phosphanium;2-[12-(1-methylimidazol-4-yl)-14-thia-8,10-diazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(16),2,4,6,9,11(15),12-heptaen-8-yl]-6-phenylfuro[3,2-d][1,3]oxazole;phenyl-[2-(2-quinolin-8-yl-5,6-dihydropyrido[2,3-b][1]benzazepin-11-yl)furo[3,2-d][1,3]oxazol-6-yl]methanethiolate;tetrakis(rhodium)?

The InChIKey is WHNLGMJMEQUTFJ-UHFFFAOYSA-N. The full InChI is InChI=1S/C39H26N5PS.C34H24N4O2S.C32H25N6O2.C28H16N5O2S.4Rh/c1-3-13-29(14-4-1)45(30-15-5-2-6-16-30)32-18-9-11-27-20-22-36(41-37(27)32)44-31-17-7-8-19-33(31)46-34-21-23-35(42-39(34)44)43-26-24-28-12-10-25-40-38(28)43;41-31(23-9-2-1-3-10-23)26-20-39-33-30(26)37-34(40-33)38-28-14-5-4-8-21(28)15-16-24-17-18-27(36-32(24)38)25-13-6-11-22-12-7-19-35-29(22)25;1-19-17-20(2)38(35-19)26-18-39-30-29(26)34-32(40-30)37(23-10-5-4-6-11-23)31-33-28-25(36(31)3)16-15-22-14-13-21-9-7-8-12-24(21)27(22)28;1-32-12-21(29-15-32)20-14-36-23-11-18-17-9-5-6-10-22(17)33(26(18)30-24(20)23)28-31-25-19(13-34-27(25)35-28)16-7-3-2-4-8-16;;;;/h1-26H;1-14,17-20,31,41H,15-16H2;4-11,15-18H,13-14H2,1-3H3;2-7,9-15H,1H3;;;;/q;;2*-1;;;;.

What are the key properties of 6-(3,5-dimethylpyrazol-1-yl)-N-(3-methyl-7,11-dihydro-6H-naphtho[1,2-e]benzimidazol-11-id-2-yl)-N-phenylfuro[3,2-d][1,3]oxazol-2-amine;diphenyl-[2-(2-pyrrolo[2,3-b]pyridin-1-ylpyrido[3,2-b][1,4]benzothiazin-10-yl)quinolin-8-yl]phosphanium;2-[12-(1-methylimidazol-4-yl)-14-thia-8,10-diazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(16),2,4,6,9,11(15),12-heptaen-8-yl]-6-phenylfuro[3,2-d][1,3]oxazole;phenyl-[2-(2-quinolin-8-yl-5,6-dihydropyrido[2,3-b][1]benzazepin-11-yl)furo[3,2-d][1,3]oxazol-6-yl]methanethiolate;tetrakis(rhodium)?

6-(3,5-dimethylpyrazol-1-yl)-N-(3-methyl-7,11-dihydro-6H-naphtho[1,2-e]benzimidazol-11-id-2-yl)-N-phenylfuro[3,2-d][1,3]oxazol-2-amine;diphenyl-[2-(2-pyrrolo[2,3-b]pyridin-1-ylpyrido[3,2-b][1,4]benzothiazin-10-yl)quinolin-8-yl]phosphanium;2-[12-(1-methylimidazol-4-yl)-14-thia-8,10-diazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(16),2,4,6,9,11(15),12-heptaen-8-yl]-6-phenylfuro[3,2-d][1,3]oxazole;phenyl-[2-(2-quinolin-8-yl-5,6-dihydropyrido[2,3-b][1]benzazepin-11-yl)furo[3,2-d][1,3]oxazol-6-yl]methanethiolate;tetrakis(rhodium) has a molecular weight of 2604.12 g/mol, XLogP of 30.76, 16 rotatable bonds, 0 hydrogen bond donors, and 29 hydrogen bond acceptors.

Where does this data come from?

All data for 6-(3,5-dimethylpyrazol-1-yl)-N-(3-methyl-7,11-dihydro-6H-naphtho[1,2-e]benzimidazol-11-id-2-yl)-N-phenylfuro[3,2-d][1,3]oxazol-2-amine;diphenyl-[2-(2-pyrrolo[2,3-b]pyridin-1-ylpyrido[3,2-b][1,4]benzothiazin-10-yl)quinolin-8-yl]phosphanium;2-[12-(1-methylimidazol-4-yl)-14-thia-8,10-diazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(16),2,4,6,9,11(15),12-heptaen-8-yl]-6-phenylfuro[3,2-d][1,3]oxazole;phenyl-[2-(2-quinolin-8-yl-5,6-dihydropyrido[2,3-b][1]benzazepin-11-yl)furo[3,2-d][1,3]oxazol-6-yl]methanethiolate;tetrakis(rhodium) is sourced from PubChem (CID 157134692), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).